| |
| |
|
| Insider
Information: |
Hunter William L |
| Relationship: |
Director |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
6,008,113 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,008,113 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Angiotech Pharmaceuticals Inc(USA) |
ANPIQ |
CEO & President, Direc... |
2009-09-29 |
5,898,091 |
2011-05-12 |
0 |
Premium* |
|
|
Epirus Biopharmaceuticals Inc |
EPRS |
Director |
2010-03-01 |
110,022 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANPIQ |
Angiotech Pharmaceuticals... |
CEO & President |
• • • |
2011-05-12 |
4 |
D |
$0.15 |
$1,363,829 |
I/I |
(5,913,691) |
0 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
71,865 |
110,022 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2010-01-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,111) |
38,157 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2009-12-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
68,268 |
|
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President & CEO |
• • – |
2009-11-20 |
4 |
B |
$1.38 |
$21,765 |
I/I |
15,600 |
5,913,691 |
2.58 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2009-09-29 |
4 |
B |
$1.89 |
$4,747 |
D/D |
2,500 |
5,898,091 |
2.73 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2009-09-29 |
4 |
B |
$1.89 |
$89,446 |
I/I |
47,000 |
5,895,591 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President & CEO |
• • – |
2009-05-05 |
4 |
B |
$0.54 |
$86,863 |
I/I |
157,738 |
5,848,591 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President & CEO |
• • – |
2009-05-04 |
4 |
B |
$0.55 |
$19,029 |
I/I |
32,143 |
5,690,853 |
2.58 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President & CEO |
• • – |
2009-05-01 |
4 |
B |
$0.54 |
$241,082 |
I/I |
444,670 |
5,658,710 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President & CEO |
• • – |
2009-03-18 |
4 |
B |
$0.33 |
$12,533 |
I/I |
30,500 |
5,214,040 |
2.58 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President & CEO |
• • – |
2009-03-17 |
4 |
B |
$0.31 |
$16,910 |
I/I |
53,000 |
5,183,540 |
2.58 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2009-03-16 |
4 |
B |
$0.31 |
$12,958 |
I/I |
40,848 |
5,130,540 |
2.58 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2009-03-13 |
4 |
B |
$0.30 |
$27,188 |
I/I |
89,692 |
5,089,692 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-23 |
4 |
B |
$0.16 |
$6,593 |
I/I |
33,000 |
5,000,000 |
2.58 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-22 |
4 |
B |
$0.16 |
$25,096 |
I/I |
156,933 |
4,967,000 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-22 |
4 |
B |
$0.15 |
$89,017 |
I/I |
567,595 |
4,810,067 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-22 |
4 |
B |
$0.15 |
$1,899 |
I/I |
12,472 |
4,242,472 |
2.58 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-19 |
4 |
B |
$0.16 |
$153,057 |
I/I |
901,513 |
4,230,000 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-18 |
4 |
B |
$0.16 |
$38,003 |
I/I |
223,631 |
3,328,487 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-17 |
4 |
B |
$0.16 |
$27,348 |
I/I |
169,761 |
3,104,856 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-17 |
4 |
B |
$0.15 |
$30,857 |
I/I |
202,250 |
2,935,095 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-15 |
4 |
B |
$0.17 |
$241,440 |
I/I |
1,396,748 |
2,715,745 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-12 |
4 |
B |
$0.16 |
$43,920 |
I/I |
263,241 |
1,318,997 |
2.66 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
President and CEO |
• • – |
2008-12-11 |
4 |
B |
$0.17 |
$27,985 |
I/I |
163,000 |
1,055,756 |
2.66 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
